Trials / Unknown
UnknownNCT05686343
Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks
Hemodynamically Important PDA in Newborns Under 32 Weeks: Clinical and Echocardiographic Findings and Outcomes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- Ankara University · Academic / Other
- Sex
- All
- Age
- 1 Minute – 7 Days
- Healthy volunteers
- —
Summary
To define the characteristics of hemodynamically significant PDA by echocardiography, to investigate the systemic effects of the ductus with cerebral and renal Doppler flow studies, and to determine the oxygen consumption in the cerebral tissue with NIRS in newborns below 32 weeks of age with PDA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Echocardiography, Doppler ultrasonography, Near-infrared spectroscopy | Ecocardiography at 1st, 3rd and 7th day of life Doppler US (cranial and renal) at 1st, 3rd and 7th day of life Near-infrared spectroscopy monitoring after birth during first 3-days of life |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
- First posted
- 2023-01-17
- Last updated
- 2023-01-17
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05686343. Inclusion in this directory is not an endorsement.